![](/img/cover-not-exists.png)
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure
Blanco, Francisco J., Rubio-Romero, Esteban, Sanmartí, Raimon, Díaz-Torné, César, Talavera, Pablo, Dunkel, Jochen, Naredo, EsperanzaLanguage:
english
Journal:
Reumatología Clínica
DOI:
10.1016/j.reuma.2018.07.009
Date:
September, 2018
File:
PDF, 692 KB
english, 2018